COVID-19 Information and Guidance
The price of cancer drugs is too high, an increasingly significant issue in U.S. health care expenditures. In this op-ed for the Washington Post, Hagop Kantarjian, scholar in health policy, explains how to reduce the price of cancer drugs.
Read the full Feb. 22, 2013, article here.
Edward M. Emmett
May 12 2022 | Center for Energy Studies
Moshe Vardi
May 12 2022 | Science & Technology Policy
View All Research »
Search Experts in the News »
View all Fellows & Scholars »